Home/Filings/4/0000950170-25-024110
4//SEC Filing

GOOD JENNIFER L 4

Accession 0000950170-25-024110

CIK 0001563880other

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 4:00 PM ET

Size

5.4 KB

Accession

0000950170-25-024110

Insider Transaction Report

Form 4
Period: 2025-02-18
GOOD JENNIFER L
DirectorPresident & CEO
Transactions
  • Award

    Stock Option (right to buy)

    2025-02-18+811,000811,000 total
    Exercise: $4.22Exp: 2035-02-17Common Stock (811,000 underlying)
Footnotes (1)
  • [F1]This option was granted on February 18, 2025. The 811,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 18, 2026 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 18, 2029.

Documents

1 file

Issuer

Trevi Therapeutics, Inc.

CIK 0001563880

Entity typeother

Related Parties

1
  • filerCIK 0001229245

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:00 PM ET
Size
5.4 KB